Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

This study is ongoing, but not recruiting participants.

Study NCT00112827 Information provided by City of Hope Medical Center

First Received: June 2, 2005 Last Updated: March 23, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2013 (Final data collection date for primary outcome measure)